$11.29 +$1.33 (+13.35%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $11.39 +0.91%
开盘$10.16
昨收$9.96
当日区间$9.99 – $12.20
成交量3.04M
市值$760.27M
市盈率（TTM）–
股息率–
DNA 相关新闻
匹配 Ginkgo Bioworks 或代码 DNA 的头条新闻，按最新排序。
- BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $5
- Kala Bio and Virotek Sign Letter of Intent With U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
- TD Cowen Downgrades Ginkgo Bioworks(DNA.US) to Hold Rating, Cuts Target Price to $9 负面
- William Blair Initiates Ginkgo Bioworks(DNA.US) With Sell Rating
- Press Release: DNA X, Inc. Reports Second Quarter 2026 Financial Results
- William Blair Maintains Ginkgo Bioworks(DNA.US) With Sell Rating
- Ginkgo Bioworks (DNA.US) will release its earnings report after market close on August 5.
- TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $12
- DNA X | 8-K: DNA X, Inc. Reports First Quarter 2026 Financial Results
- Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)
- BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $5 负面
- Sonim Technologies | 3: Initial statement of beneficial ownership of securities-10% Owner DNA Holdings Venture Inc.
- Trade.xyz announces the listing of synthetic DNA company TWST.
- TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Cuts Target Price to $12 负面
- BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Raises Target Price to $9 正面
暂无评论——快来第一个聊聊 DNA。
登录后参与讨论。